These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

Stent thrombosis (ST) is a rare but severe complication of coronary procedures with high
mortality, high relapse rate and a very complex pathophysiology. An individual's …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Background: The Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3
years after coronary artery implantation. The safety and effectiveness of BVS through this …

Cardiovascular diseases are the most distributed cause of death worldwide. Stenting of
arteries as a percutaneous transluminal angioplasty procedure became a promising …

There has been a great evolution in the development of coronary stents in order to avoid
both restenosis and thrombosis. Improvements have led to improvements in the design and …

Background: Very late scaffold thrombosis (VLScT) occurs more frequently after
bioresorbable scaffold (Absorb BVS 1.1, Abbott Vascular, Santa Clara, California) …

No obstante, la decisión final sobre el cuidado de un paciente concreto, en consulta con
dicho paciente y, si fuera necesario, con su representante legal, debe tomarla el médico …

The rapid development of 4D printing provides a potential strategy for the fabrication of
deployable medical devices (DMD). The minimally invasive surgery to implant the DMD into …

Abstract European Society of Cardiology (ESC) guidelines gave class IA indication for use of
DCB in in‐stent restenosis. However, no indication exists for the usage of DCB in de novo …